Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sustained Virological Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01146626
What this trial is testing

Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients?

Who this might be right for
Hepatitis C
Ziv Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00944684
What this trial is testing

High Dose Ribavirin in the Treatment of Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Bern 32
Large-scale testing (Phase 3)Study completedNCT01625338
What this trial is testing

Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 534
Large-scale testing (Phase 3)Study completedNCT02487030
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 255
Testing effectiveness (Phase 2)Study completedNCT01726517
What this trial is testing

Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 100
Post-approval studies (Phase 4)Study completedNCT00629824
What this trial is testing

Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 250
Post-approval studies (Phase 4)Study completedNCT01378104
What this trial is testing

100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC)

Who this might be right for
Sustained Virologic ResponseIL28B Polymorphism
The Catholic University of Korea 178
Not applicableUnknownNCT02772744
What this trial is testing

Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4

Who this might be right for
Hepatitis C
Zagazig University 250
Not applicableStudy completedNCT07687758
What this trial is testing

Non-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP Score

Who this might be right for
Hepatitis C Virus InfectionCompensated Advanced Chronic Liver DiseaseHepatocellular Carcinoma (HCC)
Siriraj Hospital 571
Testing effectiveness (Phase 2)Study completedNCT02138253
What this trial is testing

A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV

Who this might be right for
Liver FibrosisHepatic FibrosisLiver Cirrhosis+1 more
Conatus Pharmaceuticals Inc. 64
Large-scale testing (Phase 3)Study completedNCT03212521
What this trial is testing

Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 230
Large-scale testing (Phase 3)Study completedNCT01641640
What this trial is testing

Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 328
Not applicableStudy completedNCT01392742
What this trial is testing

An Observational Study on Predictive Factors of Response in Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Ribavirin

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 443
Post-approval studies (Phase 4)Study completedNCT00540345
What this trial is testing

Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 300
Not applicableStudy completedNCT02803138
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 256
Testing effectiveness (Phase 2)Study completedNCT00869661
What this trial is testing

RO5024048 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C, Genotype 1 or 4

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 413
Post-approval studies (Phase 4)UnknownNCT02008214
What this trial is testing

Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients

Who this might be right for
HepacivirusHIV Infections
Centro Universitario de Ciencias de la Salud, Mexico 60
Not applicableUnknownNCT04724785
What this trial is testing

Real World Study About Anti-viral Regimen Adjustment on Achieving Complete Response in CHB Patients

Who this might be right for
Sustained Virologic ResponseHepatitis B, Chronic
The Second Affiliated Hospital of Chongqing Medical University 10,000
Large-scale testing (Phase 3)WithdrawnNCT02099604
What this trial is testing

Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases
Post-approval studies (Phase 4)Study completedNCT01585324
What this trial is testing

The Relationship Between Drop in Hemoglobin and Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 30
Next Page